Inventor · disambiguated record
Dario C. Altieri
Also filed as: ALTIERI DARIO · ALTIERI DARIO C · ALTIERI DARIO CARLO · ALTIERI I DARIO C
27 granted patents·25 pending applications·411 citations·filing 1991–2025
97Inventor score
Files withWISTAR INST15UNIV YALE13SCRIPPS RESEARCH INST8ALTIERI DARIO C4H LEE MOFFITT CANCER CT & RES4
Top patents by PatentIndex Score
52 records- 0197US6943150B1Survivin, a protein that inhibits cellular apoptosis and its modulationUNIV YALE·Filed 2000·Granted Sep 13, 2005·54 cites·24 claims
- 0296US6245523B1Survivin, a protein that inhibits cellular apoptosis, and its modulationUNIV YALE·Filed 1997·Granted Jun 12, 2001·119 cites·28 claims
- 0393US6800737B2Survivin, a protein that inhibits cellular apoptosis, and its modulationUNIV YALE·Filed 2002·Granted Oct 5, 2004·39 cites·12 claims
- 0490US6509162B1Methods for selectively modulating survivin apoptosis pathwaysUNIV YALE·Filed 2000·Granted Jan 21, 2003·24 cites·12 claims
- 0587US11208478B2Methods of detecting and treating a tumor expressing pT346 PDK1WISTAR INST·Filed 2017·Granted Dec 28, 2021·2 cites·8 claims
- 0685US7342093B2Compounds that inhibit Hsp90 protein-protein interactions with IAP proteinsUNIV MASSACHUSETTS·Filed 2005·Granted Mar 11, 2008·10 cites·2 claims
- 0784US8466140B2Mitochondria-targeted anti-tumor agentsALTIERI DARIO C·Filed 2008·Granted Jun 18, 2013·14 cites·25 claims
- 0884US6737058B2Methods for inhibiting endothelial cell and fibrinogen mediated inflammation using fibrinogen specific antibodiesSCRIPPS RESEARCH INST·Filed 2001·Granted May 18, 2004·7 cites·4 claims
- 0984US2024342199A1Combination therapies targeting mitochondria for cancer therapyWISTAR INST·Filed 2024·Application pending·0 cites
- 1082US2024207202A1Combination therapies targeting mitochondrial biogenesis for cancer therapyWISTAR INST·Filed 2023·Application pending·0 cites
- 1181US10414810B2Double mutant survivin vaccineH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Sep 17, 2019·2 cites·10 claims
- 1280US5599790AFibrinogen γ chain polypeptide and compositions thereofSCRIPPS RESEARCH INST·Filed 1994·Granted Feb 4, 1997·33 cites·4 claims
- 1379US9987294B2Mitochondria-targeted anti-tumor agentsUNIV MASSACHUSETTS·Filed 2016·Granted Jun 5, 2018·2 cites·22 claims
- 1478US6949558B2Enhancement of taxane-based chemotherapy by a CDK1 antagonistUNIV YALE·Filed 2002·Granted Sep 27, 2005·16 cites·33 claims
- 1576US7097966B2Detection of survivin in the biological fluids of cancer patientsUNIV YALE·Filed 2002·Granted Aug 29, 2006·14 cites·38 claims
- 1675US7794926B2Detection of survivin in the biological fluids of cancer patientsUNIV YALE·Filed 2006·Granted Sep 14, 2010·4 cites·47 claims
- 1773US12344642B2Variant survivin vaccine for treatment of myelomaH LEE MOFFITT CANCER CT & RES·Filed 2021·Granted Jul 1, 2025·0 cites·12 claims
- 1873US8420777B2Compounds that inhibit Hsp90 protein-protein interactions with IAP proteinsALTIERI DARIO C·Filed 2008·Granted Apr 16, 2013·2 cites·13 claims
- 1972US11149072B2Variant survivin vaccine for treatment of myelomaH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Oct 19, 2021·0 cites·19 claims
- 2072US6676940B2Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammationSCRIPPS RESEARCH INST·Filed 2001·Granted Jan 13, 2004·1 cites·7 claims
- 2172US2023181489A1Combination therapies targeting mitochondrial biogenesis for cancer therapyWISTAR INST·Filed 2022·Application pending·0 cites
- 2272US2022113311A1Methods of Detecting and Treating a Tumor Expressing PT346 PDK1WISTAR INST·Filed 2021·Application pending·0 cites
- 2371US7553821B2Methods for selectively modulating survivin apoptosis pathwaysUNIV YALE·Filed 2002·Granted Jun 30, 2009·6 cites·7 claims
- 2470US2021186993A1Combination therapies targeting mitochondria for cancer therapyWISTAR INST·Filed 2020·Application pending·0 cites
- 2568US2025179132A1Variant survivin vaccine for treatment of cancerH LEE MOFFITT CANCER CT & RES·Filed 2025·Application pending·0 cites
- 2667US2006069025A1Survivin, a protein that inhibits cellular apoptosis, and its modulationUNIV YALE·Filed 2005·Application pending·0 cites
- 2765US6346389B1Method for selectively modulating the interactions between survivin and tubulinUNIV YALE·Filed 1999·Granted Feb 12, 2002·26 cites·40 claims
- 2864US2011136743A1Survivin, a protein that inhibits cellular apoptosis, and its modulationUNIV YALE·Filed 2009·Application pending·0 cites
- 2964US2011160278A1Methods For Selectively Modulating Survivin Apoptosis PathwaysALTIERI DARIO C·Filed 2009·Application pending·0 cites
- 3063US5919754AMethod of inhibiting fibrinogen binding to endothelial cells with fibrinogen gamma chain peptidesSCRIPPS RESEARCH INST·Filed 1996·Granted Jul 6, 1999·9 cites·4 claims
- 3163US2021069218A1Methods of controlling tumor bioenergetics networksWISTAR INST·Filed 2020·Application pending·0 cites
- 3263US2019255081A1Combination therapies targeting mitochondria for cancer therapyWISTAR INST·Filed 2019·Application pending·0 cites
- 3362US2006068453A1Survivin, a protein that inhibits cellular apoptosis, and its modulationUNIV YALE·Filed 2005·Application pending·0 cites
- 3462US2025002918A1Compositions and methods for treatment of mic60 depleted cancers and metastasisWISTAR INST·Filed 2022·Application pending·0 cites
- 3562US2023277569A1Compositions and Methods for Treating, Ameliorating and/or Preventing Cancer and Kits for the SameTHE WISTAR INST·Filed 2023·Application pending·0 cites
- 3659US2018228740A1Combination therapies targeting mitochondrial biogenesis for cancer therapyWISTAR INST·Filed 2016·Application pending·0 cites
- 3757US7776518B2Detection of survivin in the biological fluids of cancer patientsUNIV YALE·Filed 2003·Granted Aug 17, 2010·2 cites·50 claims
- 3856US9035024B2Compounds that inhibit Hsp90 protein-protein interactions with IAP proteinsUNIV MASSACHUSETTS·Filed 2013·Granted May 19, 2015·0 cites·16 claims
- 3956US5473051AInhibition of Mac-1 receptor binding to fibrinogen using D30 homologsSCRIPPS RESEARCH INST·Filed 1991·Granted Dec 5, 1995·13 cites·2 claims
- 4054US2005143308A1Survivin, a protein that inhibits cellular apoptosis, and its modulationFiled 2005·Application pending·0 cites
- 4154US2016015725A1Methods of controlling tumor bioenergetics networksWISTAR INST·Filed 2013·Application pending·0 cites
- 4252US6265549B1Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammationSCRIPPS RESEARCH INST·Filed 1999·Granted Jul 24, 2001·4 cites·2 claims
- 4352US2014271667A1Methods and Compositions for Neoadjuvant TherapyWISTAR INST·Filed 2014·Application pending·0 cites
- 4452US2017049790A1Combination therapies targeting mitochondria for cancer therapyWISTAR INST·Filed 2015·Application pending·0 cites
- 4552US2006204980A1Colorectal cancer therapiesALTIERI DARIO C·Filed 2005·Application pending·0 cites
- 4651US2022348620A1Engineered Peptide and Peptide Mimetic Compositions and MethodsWISTAR INST·Filed 2020·Application pending·0 cites
- 4749US2014142121A1Mitochondria-targeted anti-tumor agentsUNIV MASSACHSUTTS·Filed 2013·Application pending·0 cites
- 4846US6238875B1Diagnostic methods useful in the characterization of lymphoproliferative disease characterized by increased EPR-1SCRIPPS RESEARCH INST·Filed 1994·Granted May 29, 2001·6 cites·14 claims
- 4946US2011268722A1Combination therapies with mitochondrial-targeted anti-tumor agentsSIEGELIN MARKUS D·Filed 2011·Application pending·0 cites
- 5046US2008125358A1Methods for Chk2 inhibitor patient selectionUNIV MASSACHUSETTS MEDICAL·Filed 2006·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dario C. Altieri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →